- ABOUT IMC
- IoT LIBRARY
- RFP PROGRAMME
Patient monitoring start-up closes $13m funding round
- May 2, 2023
- Steve Rogerson
Neteera Technologies, an Israeli patient-monitoring start-up, has closed a $13m series B funding round.
Neteera will use the money to accelerate sales, production and deployment of its contactless patient monitoring platform and further develop its proprietary medical sensing platform. The technology is designed to enable continuous monitoring of patients’ bio markers without the need for contact or patient involvement, streamlining patient monitoring, improving outcomes and reducing the burden on clinical staff.
The round was led by healthcare investment firm Aescuvest, combined with existing and new investors, including Omega Healthcare Investors, a US firm with a focus on skilled nursing facility and assisted living facility operators across the USA and the UK, Nanz Family Office, Ankor Holding and Esas Private Equity. In addition, Omega will offer Neteera’s technology to its healthcare operating partners.
“Aescuvest is committed to funding healthcare developments that have a positive impact on society, and we believe that Neteera’s innovative technology has the potential to revolutionise the way we monitor and care for patients,” said Sebastian Gührs, head of investment at Aescuvest.
Neteera will become Omega’s partner for contactless patient monitoring and will offer its remote patient monitoring platform to Omega’s network of long-term care and skilled nursing facilities across the USA.
“We are excited to partner with Neteera,” said Matthew Gourmand, senior vice president of Omega Healthcare Investors. “We deployed their technology across a test group of facilities and received positive feedback from the operators, highlighting a reduction in hospitalisations and early recognition of changes in resident clinical needs. We believe this technology has the capacity to help caregivers, as they seek to provide high levels of care and comfort for their residents.”
Founded in 2015, Neteera gained recognition for its FDA-cleared contactless remote patient monitoring platform. The platform, capable of continuous and seamless monitoring of patients’ bio markers in real time, is improving patient care and operator efficiencies all over the globe. Together with the FDA clearance and the latest funding round, the company is poised to bring its technology to more patients in need.
“We are thrilled to partner with Aescuvest and Omega as we continue to develop and scale our game changing solution,” said Neteera CEO Isaac Litman. “With this funding and with Omega’s strategic partnership, we will be able to expand our reach and accelerate our mission to improve patient outcomes while reducing the burden on clinical staff.”